An interview with Dr. Ulrich Schotten from the Cardiovascular Research Institute Maastricht, in Maastricht, The Netherlands.
Read MoreDr. Karl-Heinz Kuck presented new advances in balloon technologies for AF ablation at AF2107.
Read MoreDr. Vivek Reddy’s talk at AF2017 highlighted advances in mapping and ablation of atrial fibrillation.
Read MoreDr. A. John Camm's session at AF2017 highlighted the importance of screening for atrial fibrillation in modern health environments.
Read MoreDr. Daniel Singer's lecture at AF2017 addressed whether patients with brief episodes of device-detected AF should be treated with anticoagulants.
Read MoreDr. Natalia Trayanova's talk at AF2017 highlighted the mechanisms underlying persistent atrial fibrillation.
Read MoreAn interview with Dr. Michel Haissaguerre offers insights into noninvasive mapping of atrial fibrillation.
Read More“The question is, what came first: the chicken or the egg?” said Nassir F. Marrouche, MD, noting that every AF patient has some kind of fibrosis or myopathy in their heart, in the atrium at least. He says research findings have sparked a debate regarding the relationship.
Read MoreSpeaking to Boston AF Symposium News, Kevin Heist (Massachusetts General Hospital, Boston, MA, USA) laid out the indications of different rate-controlling agents and his hopes as to what future research could address.
Read More“We often conclude that, as atrial fibrillation (AF) occurs with increasing frequency with advancing age in both men and women, the occurrence of AF is inevitable,” said David Van Wagoner, PhD, ahead of his presentation.
Read MoreHiroshi Nakagawa, MD, PhD, compares existing balloon technologies versus new radiofrequency ablation systems, including the benefits and efficacy of the cryoballoon and laser balloon in patients with atrial fibrillation.
Read MoreWhat percentage of atrial fibrillation (AF) patients with an ICD and congestive heart failure can be considered for catheter ablation? Dr. Andrea Natale responds.
Read MoreThe impact of left atrial appendage (LAA) closure on atrial fibrillation and the function of the left atrium formed the basis of an insightful talk from Dhanunjaya Lakkireddy (University of Kansas Medical Center, Kansas) during a session on protecting the brain in AF.
Read MoreThe utility, procedural benefits and comparative efficacy of a 252-electrode noninvasive mapping system for AF will be placed under the spotlight this afternoon, with Sebastien Knecht (Brugmann University Hospital, Brussels, Belgium) outlining key results from the ongoing AFACART trial.
Read MoreDr. Allessie and colleagues say, in recent years, a growing number of scientists and physicians have started to believe that persistent AF is maintained by a single stable rotor somewhere in the atrial wall.
Read MoreMarking the very first presentation of the 2015 AF Symposium, Prashanthan Sanders from the Royal Adelaide Hospital, Australia, kick-started proceedings on Thursday morning with an exploration of the mechanisms of atrial remodeling and their impact of AF outcomes.
Read MoreProfessor Haissaguerre and colleagues applied noninvasive signal processing to identify driver domains in 103 patients, demonstrating that driver sites can be mapped accurately, leading to shorter RF times than conventional ablation techniques. He discussed the work in an interview with AF Symposium News.
Read MoreDr. Albert Waldo (Case Western Reserve University, speaks about putting multiple reentrant wavelets to rest – at least in the Moe model.
Read MoreEpicardial techniques present advantages over some aspects of endocardial devices, as long as patients have anatomies that do not preclude their use, but more data across the board regarding efficacy and safety is still needed, Drs. Vivek Reddy and Moussa Mansour discuss.
Read MoreProfessor Camm noted various studies that have achieved great results in terms of characterizing best treatment options for certain patient groups, from antiarrhythmia drugs to ablation, surgery to electrophysiology.
Read More
